 |
Nearly quarter of PPP projects abandoned in MenaNearly one in four public private partnership (PPP) projects launched in the Middle East and North Africa (Mena) region are abandoned, owing to poorly structured deals and lack of detailed feasibility, according to a report. The p More… |
 |
Egypt to set up cross-continent shipping lineEgypt has signed a grant agreement with the African Development Bank (AfDB) worth $650,000 in order to finance the feasibility studies for the establishment of a cross-continent shipping line, a report said. Egypt’s Ministry More… |
 |
Qapco, CNA-Q in deal for vocational studies in QatarQatar Petrochemical Company (Qapco) and the College of the North Atlantic – Qatar (CNA-Q) have signed a deal to create a ‘Professional Chair of Vocational Studies’ in Qatar. It will assist in building a strategic More… |
|
Qapco, CNA-Q in deal for vocational studies in QatarQatar Petrochemical Company (Qapco) and the College of the North Atlantic – Qatar (CNA-Q) have signed a deal to create a ‘Professional Chair of Vocational Studies’ in Qatar. It will assist in building a strategic More… |
 |
Why case studies are important for a businessWhat options do clients have when choosing whether a product or service is right for them? Let’s take a look at the different options clients have available to them, and assess whether they are in f More… |
 |
US Embassy in Bahrain offers scholarshipsThe US Embassy in Bahrain is offering two scholarship and fellowship programmes to Bahraini students for graduate level study in the US for the 2014-2015 academic year. The Fulbright Graduate Scholarship provides two years of full More… |
 |
Bahrain ministry studies standardisation issuesBahrain Industry and Commerce Minister Dr Hassan Fakhro chaired the 40th National Committee for Standardisation and Metrology in the presence of committee representatives of public and private sectors and a number of experts. They discuss More… |
 |
Studies conflict on Glaxo diabetes drug riskTwo studies conducted in the US reported serious heart risks with GlaxoSmithKline Plc's diabetes pill Avandia while a third contradicted those findings, adding to a debate over whether the drug should stay on the market. The conflictin More… |
